Gelman-Hikari Research: selective hydrolysis of the commercially available NAD+ (Nicotinamide adenine dinucleotide) to the biologically active NR (nicotinamide riboside)
Latest
Join Yissum and HUJI Pulse on June 9th to hear from leading female experts, driving innovation and changing healthcare.
Israeli researcher, Prof. Hermona Soreq and others in her lab, said Friday they have developed a simple, "revolutionary" blood test that for the first time would allow doctors to detect the onset of Parkinson's disease in its very earliest stages.
The Yissum Spring 2025 Newsletter features Salignostics’ Salistick launch in Germany, new tech from HUJI, and success stories from Solra PV, CollPlant, and Pharmaseed.
